{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:17:48Z","timestamp":1649107068487},"reference-count":11,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.7888\/juoeh.42.359","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T22:15:07Z","timestamp":1606774507000},"page":"359-364","source":"Crossref","is-referenced-by-count":0,"title":["Short-term Glucose Lowering Effects of Sodium-glucose Cotransporter 2 Inhibitors Confirmed by Flash Glucose Monitoring in Two Outpatients with Type 1 Diabetes"],"prefix":"10.7888","volume":"42","author":[{"given":"Momoko","family":"HABU","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"OKADA","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"KUROZUMI","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"TANAKA","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2. Mathieu C, Dandona P, Gillard P <i>et al<\/i> (2018): Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 Study): 24-week results from a randomized controlled trial.  Diabetes Care 41(9): 1938\u22121946","DOI":"10.2337\/dc18-0623"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3. Araki E, Watada H, Uchigata Y <i>et al<\/i> (2020): Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial.  Diabetes Obes Metab 22(4): 540\u2212548","DOI":"10.1111\/dom.13922"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Kaku K, Isaka H, Sakatani T & Toyoshima J (2019): Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: a randomized, double-blind, phase 3 trial.  Diabetes Obes Metab 21(10): 2284\u22122293","DOI":"10.1111\/dom.13807"},{"key":"4","unstructured":"5. McCrimmon RJ & Henry RR (2018): SGLT inhibitor adjunct therapy in type 1 diabetes.  Diabetologia 61(10): 2126\u22122133"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Battelino T, Danne T, Bergenstal RM <i>et al<\/i> (2019): Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range.  Diabetes Care 42(8): 1593\u22121603","DOI":"10.2337\/dci19-0028"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Danne T, Cariou B, Buse JB <i>et al<\/i> (2019): Improved time in range and glycemic variability with sotagliflozin in combination with insulin in adults with type 1 diabetes: a pooled analysis of 24-week continuous glucose monitoring data from the intandem program.  Diabetes Care 42(5): 919\u2212930","DOI":"10.2337\/dc18-2149"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Torimoto K, Okada Y, Goshima Y, Tokutsu A, Sato Y & Tanaka Y (2019): Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: a randomized controlled trial.  Diabetes Obes Metab 21(9): 2174\u22122179","DOI":"10.1111\/dom.13770"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Liljenquist JE, Bomboy JD, Lewis SB <i>et al<\/i> (1974): Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.  J Clin Invest 53(1): 190\u2212197","DOI":"10.1172\/JCI107537"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Taylor SI, Blau JE & Rother KI (2015): SGLT2 inhibitors may predispose to ketoacidosis.  J Clin Endocrinol Metab 100(8): 2849\u22122852","DOI":"10.1210\/jc.2015-1884"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Garg SK, Peters AL, Buse JB & Danne T (2018): Strategy for mitigating DKA risk in patients with type 1 diabetes on adjunctive treatment with SGLT inhibitors: a STICH protocol.  Diabetes Technol Ther 20(9): 571\u2212575","DOI":"10.1089\/dia.2018.0246"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Goldenberg RM, Gilbert JD, Hramiak IM, Woo VC & Zinman B (2019): Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: the STOP DKA protocol.  Diabetes Obes Metab 21(10): 2192\u22122202","DOI":"10.1111\/dom.13811"}],"container-title":["Journal of UOEH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/42\/4\/42_359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T04:14:23Z","timestamp":1607141663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/42\/4\/42_359\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.42.359","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}